Barriers to accessing GLP-1 medications are beginning to break down as drug manufacturers, insurers, and lawmakers look to expand availability, lower costs, and address continued high demand.

Randomised controlled trials and real word evidence have consistently shown that GLP-1 receptor agonists are effective and ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

Now, research from Henry Ford Health, has found that weight-loss drugs, including GLP-1, could also impact alcohol ...

The new guidance includes updates on diabetes technology use, GLP-1 receptor agonists, liver disease, drinking water, and ...

New findings presented at ASH indicated that GLP-1 agonists led to a significant reduction in the risk for dangerous blood ...

The agency is due to make a determination on the shortage status of Zepbound by Dec. 19. But another delay could be possible ...

Taiwan says China sending largest naval fleet in years to region The Saudi Arabia diabetes drug market is a vital segment of the pharmaceutical industry, catering to the needs of a significant portion ...

Meta-analysis was performed using RevMan v5.3 and Stata/SE v15.1. Conclusion: Current evidence suggests that BBR alone or in combination has significant ... HDL-C, TC, TG); 4) inflammatory markers ...